<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01944488</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-631-12</org_study_id>
    <nct_id>NCT01944488</nct_id>
  </id_info>
  <brief_title>LH Response to GnRH Test in Prepubescent Girls Under 6 Years</brief_title>
  <official_title>LH Response to GnRH Test in Prepubescent Girls Under 6 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project aims to establish the normal LH and FSH response to a standardized GnRH dose in
      healthy girls below 6 years of age, and compares the normal GnRH response to the GnRH
      response in girls with early puberty development.

      The novel data may help to determine whether the girl is in early puberty or not.

      Healthy girls under 6 years of age attending routine examinations including an i.v. line for
      other causes are included in this study. Our examinations also include bone age
      determination, Tanner stage determination, and anthropometric measures (height and weight).
      10 healthy girls in each of the following age groups: 7-12 months, 12-24 months, 24-36
      months, 36-48 months, 48-60 months and 60-72 months are included.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please refer to the brief summary which covers the study aim, methods and outcome measures.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LH response</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>FSH response</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Up till age 6.0 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Height</measure>
    <time_frame>Up till age 6.0 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Tanner-stage (breast and pubic hair)</measure>
    <time_frame>Up till age 6.0 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Bone age</measure>
    <time_frame>Up till age 6.0 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hormones (estrogen, inhibin B, SHBG, kisspeptin)</measure>
    <time_frame>Up till age 6.0 years</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Precocious Puberty</condition>
  <arm_group>
    <arm_group_label>GnRH intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participating subjects are assigned to receive an intravenous GnRH agonist injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GnRH agonist</intervention_name>
    <description>100 µg/m2 body surface max 100 µg i.v.</description>
    <arm_group_label>GnRH intervention</arm_group_label>
    <other_name>LHRH agonist</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endocrinologically healthy girls in the age from 7 months to 6 years

          -  Obtained oral and written informed consent from participants parents

        Exclusion Criteria:

          -  Anamnestic, clinical or laboratory findings that indicate that the subject is
             suffering from other diseases (eg poorly controlled asthma) or is in a condition which
             might affect the subject's ability to complete the study or which is likely to affect
             the parameters under investigation.

          -  Current medical treatment apart from prophylactic antibiotics or weak analgesics.

          -  GFR &lt;50 ml/min/1,73m2 or if absence of previous GFR study: serum creatinine above
             normal upper age-specific normal range.

          -  Clinical signs of precocious puberty
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>7 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niels H. Birkebæk, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Børneafdeling A, AUH, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Esben T. Vestergaard, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Børneafdeling A, AUH, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kurt Kristensen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Børneafdeling A, AUH, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Søren Rittig, MD DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Børneafdeling A, AUH, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kostas Kamperis, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Børneafdeling A, AUH, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mia E. Sømod, Stud.med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Børneafdelig A, AUH, Skejby</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Niels H. Birkebæk, MD PhD</last_name>
    <phone>+45 50860090</phone>
    <email>nielbirk@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mia E. Sømod, Stud. med</last_name>
    <phone>+45 60199810</phone>
    <email>mia.elbek.somod@studmed.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Børneafdelingen A, AUH, Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Niels H. Birkebæk, Dr.med, PhD</last_name>
      <phone>+45 50860090</phone>
      <email>nielbirk@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Mia E. Sømod, Stud.med</last_name>
      <phone>+45 60199810</phone>
      <email>mia.elbek.somod@studmed.au.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Niels H. Birkebæk, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esben T. Vestergaard, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kurt Kristensen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Søren Rittig, MD DMSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kostas Kamperis, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mia E. Sømod, Stud.med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Carel JC, Léger J. Clinical practice. Precocious puberty. N Engl J Med. 2008 May 29;358(22):2366-77. doi: 10.1056/NEJMcp0800459. Review.</citation>
    <PMID>18509122</PMID>
  </reference>
  <reference>
    <citation>Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A. Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics. 2005 Dec;116(6):1323-8.</citation>
    <PMID>16322154</PMID>
  </reference>
  <reference>
    <citation>Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, Hasemeier CM. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997 Apr;99(4):505-12.</citation>
    <PMID>9093289</PMID>
  </reference>
  <reference>
    <citation>Houk CP, Kunselman AR, Lee PA. The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate. J Pediatr Endocrinol Metab. 2008 Dec;21(12):1113-8.</citation>
    <PMID>19189683</PMID>
  </reference>
  <reference>
    <citation>Curfman AL, Reljanovic SM, McNelis KM, Dong TT, Lewis SA, Jackson LW, Cromer BA. Premature thelarche in infants and toddlers: prevalence, natural history and environmental determinants. J Pediatr Adolesc Gynecol. 2011 Dec;24(6):338-41. doi: 10.1016/j.jpag.2011.01.003.</citation>
    <PMID>22099730</PMID>
  </reference>
  <reference>
    <citation>Atay Z, Turan S, Guran T, Furman A, Bereket A. The prevalence and risk factors of premature thelarche and pubarche in 4- to 8-year-old girls. Acta Paediatr. 2012 Feb;101(2):e71-5. doi: 10.1111/j.1651-2227.2011.02444.x. Epub 2011 Sep 23.</citation>
    <PMID>21854448</PMID>
  </reference>
  <reference>
    <citation>de Vries L, Guz-Mark A, Lazar L, Reches A, Phillip M. Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. J Pediatr. 2010 Mar;156(3):466-71. doi: 10.1016/j.jpeds.2009.09.071. Epub 2009 Nov 14.</citation>
    <PMID>19914634</PMID>
  </reference>
  <reference>
    <citation>Resende EA, Lara BH, Reis JD, Ferreira BP, Pereira GA, Borges MF. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab. 2007 Apr;92(4):1424-9. Epub 2007 Feb 6.</citation>
    <PMID>17284632</PMID>
  </reference>
  <reference>
    <citation>Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, Jorge BH, Arnhold IJ, Mendonca BB. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab. 1999 Oct;84(10):3539-44.</citation>
    <PMID>10522992</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2013</study_first_submitted>
  <study_first_submitted_qc>September 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2013</study_first_posted>
  <last_update_submitted>September 12, 2013</last_update_submitted>
  <last_update_submitted_qc>September 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Precocious puberty</keyword>
  <keyword>GnRH-test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Puberty, Precocious</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deslorelin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

